Opioids

FILE - This May 8, 2007, file photo shows the Purdue Pharma logo at its offices in Stamford, Conn. (AP Photo/Douglas Healey, File)
September 17, 2019 - 5:24 pm
WHITE PLAINS, N.Y. (AP) — A judge cleared the way Tuesday for OxyContin maker Purdue Pharma to stay in business while it pursues bankruptcy protection and settlement of more than 2,600 lawsuits filed against it in a reckoning over the opioid crisis. At the first court hearing since the Chapter 11...
Read More
FILE - In this Aug. 17, 2018, file photo, Lynn Wencus of Wrentham, Mass., holds a sign with a picture of her son Jeff and wears a sign of others' loved ones lost to OxyContin and other opioids during a protest at Purdue Pharma LLP headquarters in Stamford, Conn. Some of the money in Purdue Pharma’s proposed multibillion-dollar opioid settlement would come from the continued sale of opioids. “It’s blood money paying for blood money,” said Wencus. “It’s ludicrous. The whole thing would be almost comical if we weren’t talking about human lives here.” (AP Photo/Jessica Hill, File)
September 17, 2019 - 4:20 pm
The tentative multibillion-dollar settlement with OxyContin maker Purdue Pharma would raise money to help clean up the opioid mess by ... selling more OxyContin. That would amount to blood money, in the opinion of some critics. And it's one reason two dozen states have rejected the deal. "The...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 17, 2019 - 7:29 am
NEW YORK (AP) — Purdue Pharma gets its day in court Tuesday after the OxyContin maker filed for bankruptcy and negotiated a potential multi-billion dollar settlement to resolve thousands of lawsuits. An initial hearing will be held in federal court in White Plains, New York, for the Chapter 11...
Read More
FILE - This Feb. 19, 2013, file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. Purdue Pharma, the company which makes OxyContin and other drugs, filed court papers in New York on Sunday, Sept. 15, 2019, seeking Chapter 11 bankruptcy protection. (AP Photo/Toby Talbot, File)
AP News
September 16, 2019 - 4:48 pm
BOSTON (AP) — OxyContin maker Purdue Pharma has embarked on a multibillion-dollar plan to settle thousands of lawsuits over the nation's deadly opioid crisis by transforming itself in bankruptcy court into a sort of hybrid between a business and a charity. Whether the company can pull it off...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 16, 2019 - 2:26 pm
Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy in White Plains, New York, days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids. The filing was anticipated before...
Read More
FILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection. (AP Photo/Jeff Chiu, File)
September 16, 2019 - 2:09 am
OxyContin maker Purdue Pharma has filed for bankruptcy protection. But that doesn't mean the company or the family that owns it is off the legal hook. States are divided on whether to accept a tentative settlement with the company as part of the bankruptcy. Several of those who have declined it...
Read More
FILE - This Jan. 11, 2018 file photo shows Judge Dan Polster in his office, in Cleveland. Attorneys representing eight drug distributors, pharmacies and retailers facing trial for their roles in the national opioid crisis are seeking to disqualify the federal judge overseeing their cases saying he’s shown clear bias in his efforts to obtain a multi-billion dollar global settlement. The motion was filed late Friday, Sept. 13, 2019, in U.S. District Court in Cleveland, where Judge Dan Polster presides over most of the 2,000 lawsuits filed by state, local and tribal governments. Polster has not responded. (AP Photo/Tony Dejak, File)
September 14, 2019 - 4:27 pm
CLEVELAND (AP) — Attorneys for eight drug distributors, pharmacies and retailers facing trial next month for their roles in the opioid crisis want to disqualify the federal judge overseeing their cases, saying he has shown bias in his effort to obtain a multibillion-dollar global settlement...
Read More
Cars pass Purdue Pharma headquarters Thursday, Sept. 12, 2019, in Stamford, Conn. For months, the judge overseeing national litigation over the opioids crisis urged all sides to reach a settlement that could end thousands of lawsuits filed by state and local governments. But the chaotic developments this week in the case against OxyContin maker Purdue Pharma underscore how difficult that goal is. (AP Photo/Frank Franklin II)
September 13, 2019 - 11:11 pm
NEW YORK (AP) — The family that owns OxyContin maker Purdue Pharma used Swiss and other hidden accounts to transfer $1 billion to themselves, New York's attorney general contends in court papers filed Friday. New York — asking a judge to enforce subpoenas of companies, banks and advisers to Purdue...
Read More
Map shows state party and decision over Purdue settlement terms; 2c x 3 inches; 96.3 mm x 76 mm;
September 13, 2019 - 10:20 pm
MINNEAPOLIS (AP) — The opioid crisis has hit virtually every pocket of the U.S., from rural towns in deeply conservative states to big cities in liberal-leaning ones. But a curious divide has opened up. The nation's Republican state attorneys general have, for the most part, lined up in support of...
Read More
September 13, 2019 - 1:13 pm
In a story Sept. 12 about the impact of a possible Purdue Pharma bankruptcy on the Sackler family, The Associated Press reported erroneously who founded Purdue Pharma and when. Mortimer, Raymond and Arthur Sackler purchased Purdue Frederick in 1952; they did not found Purdue Pharma that year...
Read More

Pages